多発性硬化症
出典: フリー百科事典『ウィキペディア（Wikipedia）』 (2024/02/29 08:47 UTC 版)
多発性硬化症（たはつせいこうかしょう、英: multiple sclerosis; MS）は、中枢性脱髄疾患の一つで、神経のミエリン鞘が破壊され脳、脊髄、視神経などに病変が起こり、多様な神経症状が再発と寛解を繰り返す疾患。日本では特定疾患に認定されている指定難病である。
- ^ a b c 多発性硬化症 （MS） MSDマニュアル家庭版
- ^ “多発性硬化症（MS）のあらまし”. 多発性硬化症・視神経脊髄炎・MOG抗体関連疾患情報提供サイト MSキャビン (2023年). 2023-2-29閲覧。
- ^ 多発性硬化症の発症にはヨーネ菌が関与する可能性 〜死菌の経口摂取がリスクになる〜 学校法人 順天堂 医学部附属病院[リンク切れ]
- ^ Ascherio A, Munch M (2000). "Epstein-Barr virus and multiple sclerosis". Epidemiology. 11 (2): 220-4., PMID 11021623.
- ^ Ascherio A, Munger KL, Lennette ET, Spiegelman D, Hernán MA, Olek MJ, Hankinson SE, Hunter DJ (2001). "Epstein-Barr virus antibodies and risk of multiple sclerosis: a prospective study". JAMA. 286 (24): 3083-8., PMID 11754673, doi:10.1001/jama.286.24.3083.
- ^ Serafini B, Rosicarelli B, Franciotta D, Magliozzi R, Reynolds R, Cinque P, Andreoni L, Trivedi P, Salvetti M, Faggioni A, Aloisi F (2007). "Dysregulated Epstein-Barr virus infection in the multiple sclerosis brain". Journal of Experimental Medicine. 204 (12): 2899-912., PMC 2118531, PMID 17984305, doi:10.1084/jem.20071030.
- ^ Levin LI, Munger KL, Rubertone MV, Peck CA, Lennette ET, Spiegelman D, Ascherio A (2005). "Temporal Relationship Between Elevation of Epstein-Barr Virus Antibody Titers and Initial Onset of Neurological Symptoms in Multiple Sclerosis". JAMA. 293 (20): 2496-500. PMID 15914750, doi:10.1001/jama.293.20.2496.
- ^ Cepok S, Zhou D, Srivastava R, Nessler S, Stei S, Büssow K, Sommer N, Hemmer B (2005). "Identification of Epstein-Barr virus proteins as putative targets of the immune response in multiple sclerosis". The Journal of Clinical Investigation. 115 (5): 1352-60., PMC 1077174, PMID 15841210, doi:10.1172/JCI23661.
- ^ Alotaibi S, Kennedy J, Tellier R, Stephens D, Banwell B (2004). "Epstein-Barr virus in pediatric multiple sclerosis". JAMA. 291 (15): 1875-9., PMID 15100207, doi:10.1001/jama.291.15.1875.
- ^ Sundström P, Juto P, Wadell G, Hallmans G, Svenningsson A, Nyström L, Dillner J, Forsgren L (2004). "An altered immune response to Epstein-Barr virus in multiple sclerosis: a prospective study". Neurology. 62 (12): 2277-82., PMID 15210894, doi:10.1212/01.WNL.0000130496.51156.D7.
- ^ Levin LI, Munger KL, O'Reilly EJ, Falk KI, Ascherio A (2010). "Primary infection with the Epstein-Barr virus and risk of multiple sclerosis". Annals of Neurology. 67 (6): 824-30., PMC 3089959, PMID 20517945, doi:10.1002/ana.21978.
- ^ Pohl D, Krone B, Rostasy K, Kahler E, Brunner E, Lehnert M, Wagner HJ, Gärtner J, Hanefeld F (2006). "High seroprevalence of Epstein-Barr virus in children with multiple sclerosis". Neurology. 67 (11): 2063-5., PMID 17159123, doi:10.1212/01.WNL.0000247665.94088.8D.
- ^ DeLorenze GN, Munger KL, Lennette ET, Orentreich N, Vogelman JH, Ascherio A (2006). "Epstein-Barr virus and multiple sclerosis: evidence of association from a prospective study with long-term follow-up". Archives of Neurology. 63 (6): 839-44., PMID 16606758, doi:10.1001/archneur.63.6.noc50328.
- ^ Martyn CN, Cruddas M, Compston DA (1993). "Symptomatic Epstein-Barr virus infection and multiple sclerosis". Journal of Neurology, Neurosurgery & Psychiatry. 56 (2): 167-8., PMC 1014816, PMID 8382268.
- ^ Ascherio A, Munger KL (2010). "Epstein–Barr Virus Infection and Multiple Sclerosis: A Review". Journal of Neuroimmune Pharmacology. 5 (3): 271-7., PMID 20369303, doi:10.1007/s11481-010-9201-3.
- ^ De Jager PL, Simon KC, Munger KL, Rioux JD, Hafler DA, Ascherio A (2008). "Integrating risk factors: HLA-DRB1*1501 and Epstein-Barr virus in multiple sclerosis". Neurology. 70 (13 Part 2): 1113-8. PMID 18272866 doi: 10.1212/01.wnl.0000294325.63006.f8.
- ^ Bray PF, Bloomer LC, Salmon VC, Bagley MH, Larsen PD (1983). "Epstein-Barr virus infection and antibody synthesis in patients with multiple sclerosis". Archives of Neurology. 40 (7): 406-8., PMID 6860175,doi:10.1001/archneur.1983.04050070036006.
- ^ Sumaya CV, Myers LW, Ellison GW (1980). "Epstein-Barr virus antibodies in multiple sclerosis". Archives of Neurology. 37 (2): 94-6. PMID 6243930, doi:10.1001/archneur.1980.00500510052009.
- ^ Larsen PD, Bloomer LC, Bray PF (1985). "Epstein-Barr nuclear antigen and viral capsid antigen antibody titers in multiple sclerosis". Neurology. 35 (3): 435-8., PMID 2983262, doi:10.1212/WNL.35.3.435.
- ^ Lünemann JD, Tintoré M, Messmer B, Strowig T, Rovira A, Perkal H, Caballero E, Münz C, Montalban X, Comabella M (2010). "Elevated Epstein-Barr virus-encoded nuclear antigen-1 immune responses predict conversion to multiple sclerosis". Annals of Neurology. 67 (2): 159-69., PMC 2848293, PMID 20225269 doi:10.1002/ana.21886.
- ^ Myhr KM, Riise T, Barrett-Connor E, Myrmel H, Vedeler C, Grønning M, Kalvenes MB, Nyland H (1988). "Altered antibody pattern to Epstein-Barr virus but not to other herpesviruses in multiple sclerosis: a population based case-control study from western Norway". Journal of Neurology, Neurosurgery & Psychiatry. 64 (4): 539-42., PMC 2170022 , PMID 9576551.
- ^ Salvetti M, Giovannoni G, Aloisi F (2009). "Epstein-Barr virus and multiple sclerosis". Current Opinion in Neurology. 22 (3): 201-6., PMID 19359987, doi:10.1097/WCO.0b013e32832b4c8d.
- ^ Sumaya CV, Myers LW, Ellison GW, Ench Y (1985). "Increased prevalence and titer of Epstein-Barr virus antibodies in patients with multiple sclerosis". Annals of Neurology. 17 (4): 371-7., PMID 2988410, doi:10.1002/ana.410170412.
- ^ Munger KL, Levin LI, O'Reilly EJ, Falk KI, Ascherio A (2011). "Anti-Epstein-Barr virus antibodies as serological markers of multiple sclerosis: a prospective study among United States military personnel". Multiple Sclerosis Journal. 17 (10): 1185-93., PMC 3179777, PMID 21685232, doi:10.1177/1352458511408991.
- ^ Haahr S, Koch-Henriksen N, Møller-Larsen A, Eriksen LS, Andersen HM (1995). "Increased risk of multiple sclerosis after late Epstein-Barr virus infection: a historical prospective study". Multiple Sclerosis Journal. 1 (2): 73-7., PMID 9345455, doi:10.1177/135245859500100203.
- ^ Pakpoor J, Disanto G, Gerber JE, Dobson R, Meier UC, Giovannoni G, Ramagopalan SV (2013). "The risk of developing multiple sclerosis in individuals seronegative for Epstein-Barr virus: a meta-analysis". Multiple Sclerosis Journal. 19 (2): 162-6., PMID 22740437, doi:10.1177/1352458512449682.
- ^ a b Pender MP (2011). "The essential role of Epstein-Barr virus in the pathogenesis of multiple sclerosis". The Neuroscientist. 17 (4): 351-67., PMC 3764840, PMID 21075971, doi:10.1177/1073858410381531.
- ^ Sundqvist E, Sundström P, Lindén M, Hedström AK, Aloisi F, Hillert J, Kockum I, Alfredsson L, Olsson T (2012). "Epstein-Barr virus and multiple sclerosis: interaction with HLA". Genes & Immunity. 13 (1): 14-20. ,PMID 21776012, doi:10.1038/gene.2011.42.
- ^ Buljevac D, van Doornum GJ, Flach HZ, Groen J, Osterhaus AD, Hop W, van Doorn PA, van der Meché FG, Hintzen RQ (2005). "Epstein-Barr virus and disease activity in multiple sclerosis". Journal of Neurology, Neurosurgery & Psychiatry. 76 (10): 1377-81., PMC 1739347, PMID 16170080, doi:10.1136/jnnp.2004.048504.
- ^ Haahr S, Plesner AM, Vestergaard BF, Höllsberg P (2004). "A role of late Epstein-Barr virus infection in multiple sclerosis". Acta Neurology Scandinavica. 109 (4): 270-5., PMID 15016009.
- ^ Munch M, Riisom K, Christensen T, Møller-Larsen A, Haahr S (1998). "The significance of Epstein-Barr virus seropositivity in multiple sclerosis patients?". Acta Neurology Scandinavica. 97 (3): 171-4., PMID 9531433.
- ^ Höllsberg P, Hansen HJ, Haahr S (2003). "Altered CD8+ T cell responses to selected Epstein-Barr virus immunodominant epitopes in patients with multiple sclerosis". Clinical & Experimental Immunology. 132 (1): 137-43., PMC 1808679, PMID 12653848, doi:10.1046/j.1365-2249.2003.02114.x.
- ^ Sargsyan SA, Shearer AJ, Ritchie AM, Burgoon MP, Anderson S, Hemmer B, Stadelmann C, Gattenlöhner S, Owens GP, Gilden D, Bennett JL (2010). "Absence of Epstein-Barr virus in the brain and CSF of patients with multiple sclerosis". Neurology. 74 (14): 1127-35., PMC 2865779 PMID 20220124, doi:10.1212/WNL.0b013e3181d865a1.
- ^ Willis SN, Stadelmann C, Rodig SJ, Caron T, Gattenloehner S, Mallozzi SS, Roughan JE, Almendinger SE, Blewett MM, Brück W, Hafler DA, O'Connor KC (2009). "Epstein-Barr virus infection is not a characteristic feature of multiple sclerosis brain". Brain. 132 (Pt 12): 3318-28., PMC 2792367, PMID 19638446, doi:10.1093/brain/awp200.
- ^ Hilton DA, Love S, Fletcher A, Pringle JH (1994). "Absence of Epstein-Barr virus RNA in multiple sclerosis as assessed by in situ hybridisation". Journal of Neurology, Neurosurgery & Psychiatry. 57 (8): 975-6., PMC 1073085, PMID 7520057.
- ^ Lassmann H, Niedobitek G, Aloisi F, Middeldorp JM; NeuroproMiSe EBV Working Group (2011). "Epstein-Barr virus in the multiple sclerosis brain: a controversial issue--report on a focused workshop held in the Centre for Brain Research of the Medical University of Vienna, Austria". Brain. 134 (Pt 9): 2772-86., PMC 3170536, PMID 21846731, doi:10.1093/brain/awr197.
- ^ a b ^ 自己免疫疾患の引き金となるウイルス因子を同定リソウ 2015年8月25日
- ^ a b ^ 【坂口至徳の科学の現場を歩く】 誰もが感染ヘルペス…EBウイルスの因子を解明 阪大、自己免疫疾患の治療に道産経WEST 2015年8月28日
- ^ a b c Minamitani T, Yasui T, Ma Y, Zhou H, Okuzaki D, Tsai CY, Sakakibara S, Gewurz BE, Kieff E, Kikutani H (2015). "Evasion of affinity-based selection in germinal centers by Epstein-Barr virus LMP2A". Proceedings of the National Academy of Sciences of the United States of America. 112 (37): 11612-7., PMC 4577157, PMID 26305967, doi:10.1073/pnas.1514484112.
- ^ Pender MP (2003). "Infection of autoreactive B lymphocytes with EBV, causing chronic autoimmune diseases". Trends in Immunology. 24 (11): 584-8., PMID 14596882, doi:10.1016/j.it.2003.09.005.
- ^ Pender MP (2012). "CD8+ T-Cell Deficiency, Epstein-Barr Virus Infection, Vitamin D Deficiency, and Steps to Autoimmunity: A Unifying Hypothesis". Autoimmune Diseases. 2012: 189096., PMC 3270541, PMID 22312480, doi:10.1155/2012/189096.
- ^ Laurence M, Benito-León J (2017). "Epstein-Barr virus and multiple sclerosis: Updating Pender's hypothesis". Multiple Sclerosis and Related Disorders. 16: 8-14., PMID 28755684, doi:10.1016/j.msard.2017.05.009.
- ^ Pender MP, Csurhes PA, Burrows JM, Burrows SR (2017). "Defective T-cell control of Epstein-Barr virus infection in multiple sclerosis". Clinical & Translational Immunology. 6 (1): e126., PMC 292561, PMID 28197337, doi:10.1038/cti.2016.87.
- ^ Sariqa Wagley et al (2018). “Evidence of Clostridium perfringens epsilon toxin associated with multiple sclerosis”. Multiple Sclerosis Journal. [1]
- ^ Annu Rev Immunol. 2005;23:683-747. PMID 15771584
- ^ Nat Rev Immunol. 2015 Sep 15;15(9):545-58. PMID 26250739
- ^ Acta Neuropathol. 2017 Feb;133(2):223-244. PMID 27766432
- ^ J Neuroimmunol. 2010 Apr 15;221(1-2):7-14. PMID 19931190
- ^ Lancet Neurol. 2015 Apr;14(4):406-19. PMID 25792099
- ^ J Neurol. 1993 240 41-45. PMID 8423462
- ^ Clin Neurol Neurosurg. 1998 100 199-204. PMID 9822842
- ^ Ann Neurol. 2009 Mar;65(3):239-48. PMID 19334069
- ^ Annu Rev Neurosci. 2008;31:247-69. PMID 18558855
- ^ Nat Rev Neurosci. 2012 Jun 20;13(7):507-14. PMID 22714021
- ^ J Neuroimmunol. 1998 Jun 15;86(2):213-7. PMID 9663568
- ^ Acta Neuropathol. 2017 Jan;133(1):13-24. PMID 27988845
- ^ Ann Neurol. 1995 Nov;38(5):788-96. PMID 7486871
- ^ a b Ann Neurol. 2015 Nov;78(5):710-21. PMID 26239536
- ^ Ann Neurol. 2000 Jun;47(6):707-17. PMID 10852536
- ^ Ann Neurol. 2014 May;75(5):728-38. PMID 24771535
- ^ Ann Neurol. 2004 Apr;55(4):458-68. PMID 15048884
- ^ Mult Scler. 2002 Apr;8(2):93-7. PMID 11990878
- ^ Ann Neurol. 2001 Nov;50(5):646-57. PMID 11706971
- ^ a b Brain. 2005 Nov;128(Pt 11):2705-12. PMID 16230320
- ^ Brain. 2007 Apr;130(Pt 4):1089-104. PMID 17438020
- ^ Ann Neurol. 2010 Oct;68(4):477-93. PMID 20976767
- ^ J Neuropathol Exp Neurol. 2007 Aug;66(8):732-9. PMID 17882017
- ^ N Engl J Med. 2011 Dec 8;365(23):2188-97. PMID 22150037
- ^ Brain. 2011 Sep;134(Pt 9):2755-71. PMID 21840891
- ^ Brain. 1994 Dec;117 ( Pt 6):1311-22. PMID 7820568
- ^ Brain. 1999 Dec;122 ( Pt 12):2279-95. PMID 10581222
- ^ PLoS One. 2013 Aug 22;8(8):e72919. PMID 23991165
- ^ Acta Neuropathol. 2012 Jun;123(6):887-900. PMID 22438105
- ^ Neuropathology. 2015 Oct;35(5):469-80. PMID 26016402
- ^ Brain. 1997 Mar;120 ( Pt 3):393-9. PMID 9126051
- ^ J Clin Invest. 2009 Jan;119(1):169-81. PMID 19104151
- ^ Science. 2016 Jan 22;351(6271):379-84. PMID 26798014
- ^ Neurosci Lett. 2015 Jun 15;597:164-9. PMID 25936593
- ^ Clin Transl Sci. 2022 Feb;15(2):442-450. PMID 34724345
- ^ CNS Drugs. 2022 Oct;36(10):1019-1030. PMID 36178589
- ^ 正山征洋、「大麻研究」『長崎国際大学論叢』 No.8 2008-03, p.265-274, 長崎国際大学
- ^ Ann Neurol. 2018 Jul;84(1):51-63. PMID 29908077
- ^ Acta Neuropathol. 2018 Apr;135(4):511-528. PMID 29441412
- ^ Neurology. 2014 Jul 15;83(3):278-86. PMID 24871874
- ^ a b Ther Adv Neurol Disord. 2022 Jan 25;15:17562864211066751. PMID 35096143
- ^ a b Nat Rev Neurol. 2022 Jan;18(1):40-55. PMID 34732831
- ^ Front Immunol. 2019 Jan 10;9:3116. PMID 30687321
- ^ Mult Scler. 2019 Dec;25(14):1915-1925. PMID 30566027
- ^ Brain. 2014 Aug;137(Pt 8):2271-86. PMID 24893707
- ^ Glia. 2018 Jul;66(7):1317-1330. PMID 29457657
[続きの解説]
多発性硬化症と同じ種類の言葉
固有名詞の分類
| 病気の別名 | tricuspid stenosis osteogenesis imperfecta 多発性硬化症 重症筋無力症 necrotizing enterocolitis |
| 脳神経疾患 | シャルコー・マリー・トゥース病 レビー小体型認知症 多発性硬化症 重症筋無力症 ベル麻痺 |
| 特定疾患 | ミトコンドリア病 びまん性汎細気管支炎 多発性硬化症 重症筋無力症 成人スティル病 |
| 免疫病 | シェーグレン症候群 血清反応陰性関節炎 多発性硬化症 重症筋無力症 関節リウマチ |
| 領域別病名 | 多発性硬化症 パーキンソン症候群 パーキンソン病 高脂血症 う蝕 |
このページでは「ウィキペディア」から多発性硬化症を検索した結果を表示しています。
Weblioに収録されているすべての辞書から多発性硬化症を検索する場合は、下記のリンクをクリックしてください。
全ての辞書から多発性硬化症を検索
Weblioに収録されているすべての辞書から多発性硬化症を検索する場合は、下記のリンクをクリックしてください。
全ての辞書から多発性硬化症を検索 - 多発性硬化症のページへのリンク
